polymers-logo

Journal Browser

Journal Browser

Polymeric Materials for Drug Delivery II

A special issue of Polymers (ISSN 2073-4360). This special issue belongs to the section "Polymer Applications".

Deadline for manuscript submissions: closed (30 January 2024) | Viewed by 19724

Special Issue Editors

Department of Chemical and Pharmaceutical Engineering, College of Materials and Chemistry and Chemical Engineering, Chengdu University of Technology, Chengdu, China
Interests: drug delivery system and new drug formulations; complex preparations, such as liposomes, nanoparticles, prodrug conjugates, and cyclodextrin inclusion complexes; freeze-drying technology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People\'s Hospital, Chengdu, China
2. School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Interests: drug delivery; nanomedicine; nanoparticles; nanomaterials; nanomaterials synthesis
Special Issues, Collections and Topics in MDPI journals
Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Interests: drug delivery; nanoliposomes; micellar drugs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Researchers have been pursuing better ways to deliver drugs to diseased tissues for a long time. There are many characteristics of a delivery system that must be considered, such as dosage forms, route, side effects, drug release, pharmacokinetics, and patient compliance. Using specifically designed polymeric materials, we can better control the variables presented in a drug delivery system so that the drug can be more effective and safer. In the field of polymer science, complex materials are being designed and developed to better deliver therapeutic agents to a specific disease site.

The Special Issue is open to valuable contributions in the field of polymeric materials-based drug delivery systems and pharmaceutical technology. The Special Issue will cover all innovative aspects of all polymeric delivery systems, including oral, pulmonary, nasal, parental and transdermal, and modes of entry such as controlled release systems, nanomedicines, liposomes, polymeric micelles, macromolecular conjugates, hydrogels, micro- and nanocapsules, protein/peptide delivery, gene delivery, siRNA delivery, and antibody targeting. Topics related to short-term and long-term biocompatibility and preclinical data of polymer-based drug delivery systems are also welcomed.

Dr. Neng Qiu
Dr. Qixiong Zhang
Dr. Lulu Cai
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Polymers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery
  • nanomedicine
  • targeted drug release
  • controlled release
  • polymer vesicles
  • polymer/drug composites
  • polymeric micelles
  • polymer-drug conjugates
  • hydrogel
  • gene/siRNA delivery
  • protein/peptide delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

18 pages, 14694 KiB  
Article
Nanostructured Poly-l-lactide and Polyglycerol Adipate Carriers for the Encapsulation of Usnic Acid: A Promising Approach for Hepatoprotection
by Benedetta Brugnoli, Greta Perna, Sara Alfano, Antonella Piozzi, Luciano Galantini, Eleni Axioti, Vincenzo Taresco, Alessia Mariano, Anna Scotto d’Abusco, Stefano Vecchio Ciprioti and Iolanda Francolini
Polymers 2024, 16(3), 427; https://doi.org/10.3390/polym16030427 - 3 Feb 2024
Cited by 2 | Viewed by 1634
Abstract
The present study investigates the utilization of nanoparticles based on poly-l-lactide (PLLA) and polyglycerol adipate (PGA), alone and blended, for the encapsulation of usnic acid (UA), a potent natural compound with various therapeutic properties including antimicrobial and anticancer activities. The development of these [...] Read more.
The present study investigates the utilization of nanoparticles based on poly-l-lactide (PLLA) and polyglycerol adipate (PGA), alone and blended, for the encapsulation of usnic acid (UA), a potent natural compound with various therapeutic properties including antimicrobial and anticancer activities. The development of these carriers offers an innovative approach to overcome the challenges associated with usnic acid’s limited aqueous solubility, bioavailability, and hepatotoxicity. The nanosystems were characterized according to their physicochemical properties (among others, size, zeta potential, thermal properties), apparent aqueous solubility, and in vitro cytotoxicity. Interestingly, the nanocarrier obtained with the PLLA-PGA 50/50 weight ratio blend showed both the lowest size and the highest UA apparent solubility as well as the ability to decrease UA cytotoxicity towards human hepatocytes (HepG2 cells). This research opens new avenues for the effective utilization of these highly degradable and biocompatible PLLA-PGA blends as nanocarriers for reducing the cytotoxicity of usnic acid. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Graphical abstract

12 pages, 2930 KiB  
Article
Hydroxyapatite/Poly (Butylene Succinate)/Metoprolol Tartrate Composites with Controllable Drug Release and a Porous Structure for Bone Scaffold Application
by Hongming Yang, Rui Pan, Yuan Zhou, Guiting Liu, Rong Chen and Shaoyun Guo
Polymers 2023, 15(21), 4205; https://doi.org/10.3390/polym15214205 - 24 Oct 2023
Cited by 1 | Viewed by 1212
Abstract
Nowadays, it is a challenge for a bone scaffold to achieve controllable drug release and a porous structure at the same time. Herein, we fabricated hydroxyapatite/poly (butylene succinate)/metoprolol tartrate (HA/PBS/MPT) composites via melt blending, aiming to provide the option of an in situ [...] Read more.
Nowadays, it is a challenge for a bone scaffold to achieve controllable drug release and a porous structure at the same time. Herein, we fabricated hydroxyapatite/poly (butylene succinate)/metoprolol tartrate (HA/PBS/MPT) composites via melt blending, aiming to provide the option of an in situ pore-forming strategy. The introduction of HA not only significantly improved the hydrophilicity of the PBS matrix by reducing the hydrophilic contact angle by approximately 36% at a 10% content, but also damaged the integrity of the PBS crystal. Both were beneficial for the penetration of phosphate-buffered saline solution into matrix and the acceleration of MPT release. Accompanied with MPT release, porous structures were formed in situ, and the HA inside the matrix was exposed. With the increase in HA content, the MPT release rate accelerated and the pore size became larger. The in vitro cytocompatibility evaluation indicated that HA/PBS/MPT composites were conductive to the adhesion, growth, and proliferation of MC3T3-E1 cells due to the HA being exposed around the pores. Thus, the MPT release rate, pore size, and cell induction ability of the HA/PBS/MPT composites were flexibly and effectively adjusted by the composition at the same time. By introducing HA, we innovatively achieved the construction of porous structures during the drug release process, without the addition of pore-forming agents. This approach allows the drug delivery system to combine controllable drug release and biocompatibility effectively, offering a novel method for bone repair material preparation. This work might provide a convenient and robust strategy for the fabrication of bone scaffolds with controllable drug release and porous structures. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

10 pages, 2529 KiB  
Article
Study on Nanomaterials with Inhibitory Effects on the Growth of Aspergillus niger
by Ziqi Qin, Yiyuan Peng, Yiting Pu, Tao Liu, Kun Qian and Huan Tang
Polymers 2023, 15(18), 3820; https://doi.org/10.3390/polym15183820 - 19 Sep 2023
Cited by 2 | Viewed by 1147
Abstract
In this paper, the inhibitory effect of various nanomaterials on the growth of Aspergillus niger was studied. Among them, copper nanorods had the most obvious inhibitory effect on the growth of Aspergillus niger. The phase of copper nanorods was modified by chitosan, [...] Read more.
In this paper, the inhibitory effect of various nanomaterials on the growth of Aspergillus niger was studied. Among them, copper nanorods had the most obvious inhibitory effect on the growth of Aspergillus niger. The phase of copper nanorods was modified by chitosan, and its inhibitory effect on the expansion of Aspergillus niger was measured. 1. Preparation of copper nanorods and chitosan@copper nanorods: Copper nanorods with a diameter of about 300–350 nm and a length of about 100–800 nm were prepared by the liquid-phase reduction method. The chitosan solution was prepared by using the characteristics of chitosan dissolved in dilute acid to prepare chitosan@copper nanorods and modify the phase of copper nanorods. 2. Determination of the inhibitory effect of various copper nanomaterials on the growth of Aspergillus niger, including Cuprous Oxide nanoparticles, copper nanorods, nano copper oxide, and copper hydroxide, which have certain inhibitory effects on the growth of Aspergillus niger. Among them, copper nanorods have a better effect. On this basis, chitosan@copper nanorods are obtained by modifying the phase of copper nanorods with chitosan. The measured antibacterial effect is that the EC50 value is 344 mg/L. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

15 pages, 3372 KiB  
Article
Well-Defined Shell-Sheddable Core-Crosslinked Micelles with pH and Oxidation Dual-Response for On-Demand Drug Delivery
by Xinfeng Cheng, Qiyang Li, Xiaomeng Sun, Yuxin Ma, Huanping Xie, Weiguang Kong, Xianchao Du, Zhenghui Zhang, Dongfang Qiu and Yong Jin
Polymers 2023, 15(9), 1990; https://doi.org/10.3390/polym15091990 - 23 Apr 2023
Cited by 7 | Viewed by 1850
Abstract
Micellar-nanocarrier-based drug delivery systems possessing characteristics such as an excellent circulation stability, inhibited premature release and on-demand site-specific release are urgently needed for enhanced therapeutic efficacy. Therefore, a novel kind of shell-sheddable core-crosslinked polymeric micelles with pH and oxidation dual-triggered on-demand drug release [...] Read more.
Micellar-nanocarrier-based drug delivery systems possessing characteristics such as an excellent circulation stability, inhibited premature release and on-demand site-specific release are urgently needed for enhanced therapeutic efficacy. Therefore, a novel kind of shell-sheddable core-crosslinked polymeric micelles with pH and oxidation dual-triggered on-demand drug release behavior was facilely constructed. The multifunctional micelles were self-assembled from a carefully designed amphiphilic triblock PEGylated polyurethane (PEG-acetal-PUBr-acetal-PEG) employing an acid-labile acetal linker at the hydrophilic–hydrophobic interface and pendant reactive bromo-containing polyurethane (PU) as the hydrophobic block, followed by a post-crosslinking via oxidation-cleavable diselenide linkages. These well-defined micelles exhibited an enhanced structural stability against dilution, achieved through the incorporation of diselenide crosslinkers. As expected, they were found to possess dual pH- and oxidation-responsive dissociation behaviors when exposure to acid pH (~5.0) and 50 mM H2O2 conditions, as evidenced using dynamic light-scattering (DLS) and atomic force microscopy (AFM) analyses. An in vitro drug release investigation showed that the drug indomethacin (IND) could be efficiently encapsulated in the micelles, which demonstrated an inhibited premature release compared to the non-crosslinked ones. It is noteworthy that the resulting micelles could efficiently release entrapped drugs at a fast rate in response to either pH or oxidation stimuli. Moreover, the release could be significantly accelerated in the presence of both acid pH and oxidation conditions, relative to a single stimulus, owing to the synergetic degradation of micelles through pH-induced dePEGylation and oxidation-triggered decrosslinking processes. The proposed shell-sheddable core-crosslinked micelles with a pH and oxidation dual-response could be potential candidates as drug carriers for on-demand drug delivery. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

14 pages, 3449 KiB  
Article
Construction and Performance Evaluation of Nicandra physalodes (Linn.) Gaertn. Polysaccharide-Based Nanogel
by Fangyan Liu, Chen Shen, Xuelian Chen, Fei Gao and Yin Chen
Polymers 2023, 15(8), 1933; https://doi.org/10.3390/polym15081933 - 19 Apr 2023
Cited by 1 | Viewed by 1590
Abstract
The nanogels made from these polysaccharides and their derivatives are often used to construct drug delivery systems owing to their biocompatible, biodegradable, non-toxic, water-soluble, and bioactive characteristics. In this work, a novel pectin with unique gelling properties was extracted from the seed of [...] Read more.
The nanogels made from these polysaccharides and their derivatives are often used to construct drug delivery systems owing to their biocompatible, biodegradable, non-toxic, water-soluble, and bioactive characteristics. In this work, a novel pectin with unique gelling properties was extracted from the seed of Nicandra physalodes (NPGP). The structural research indicated that NPGP was a low methoxyl pectin with a high content of galacturonic acid. NPGP-based nanogels (NGs) were accomplished employing the water in oil (W/O) nano-emulsion method. The cysteamine containing reduction-responsive bond and integrin-targeting RGD peptide were also grafted onto NPGP. The anti-tumor drug doxorubicin hydrochloride (DOX) was loaded during the formation of NGs, and the performance of DOX delivery was studied. The NGs were characterized by UV-vis, DLS, TEM, FT-IR, and XPS. The results showed that the prepared NGs were nanosized (167.6 ± 53.86 nm), had excellent encapsulation efficiency (91.61 ± 0.85%), and possessed a fine drug loading capacity (8.40 ± 0.16%). The drug release experiment showed that DOX@NPGP-SS-RGD had good redox-responsive performance. Furthermore, the results of cell experiments revealed good biocompatibility of prepared NGs, along with selective absorption by HCT-116 cells through integrin receptor-mediated endocytosis to play an anti-tumor effect. These studies indicated the potential application of NPGP-based NGs as targeted drug delivery systems. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

Review

Jump to: Research

26 pages, 3788 KiB  
Review
Advancing Drug Delivery Paradigms: Polyvinyl Pyrolidone (PVP)-Based Amorphous Solid Dispersion for Enhanced Physicochemical Properties and Therapeutic Efficacy
by Agus Rusdin, Amirah Mohd Gazzali, Nur Ain Thomas, Sandra Megantara, Diah Lia Aulifa, Arif Budiman and Muchtaridi Muchtaridi
Polymers 2024, 16(2), 286; https://doi.org/10.3390/polym16020286 - 20 Jan 2024
Cited by 10 | Viewed by 3121
Abstract
Background: The current challenge in drug development lies in addressing the physicochemical issues that lead to low drug effectiveness. Solubility, a crucial physicochemical parameter, greatly influences various biopharmaceutical aspects of a drug, including dissolution rate, absorption, and bioavailability. Amorphous solid dispersion (ASD) has [...] Read more.
Background: The current challenge in drug development lies in addressing the physicochemical issues that lead to low drug effectiveness. Solubility, a crucial physicochemical parameter, greatly influences various biopharmaceutical aspects of a drug, including dissolution rate, absorption, and bioavailability. Amorphous solid dispersion (ASD) has emerged as a widely explored approach to enhance drug solubility. Objective: The objective of this review is to discuss and summarize the development of polyvinylpyrrolidone (PVP)-based amorphous solid dispersion in improving the physicochemical properties of drugs, with a focus on the use of PVP as a novel approach. Methodology: This review was conducted by examining relevant journals obtained from databases such as Scopus, PubMed, and Google Scholar, since 2018. The inclusion and exclusion criteria were applied to select suitable articles. Results: This study demonstrated the versatility and efficacy of PVP in enhancing the solubility and bioavailability of poorly soluble drugs. Diverse preparation methods, including solvent evaporation, melt quenching, electrospinning, coprecipitation, and ball milling are discussed for the production of ASDs with tailored characteristics. Conclusion: PVP-based ASDs could offer significant advantages in the formulation strategies, stability, and performance of poorly soluble drugs to enhance their overall bioavailability. The diverse methodologies and findings presented in this review will pave the way for further advancements in the development of effective and tailored amorphous solid dispersions. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

30 pages, 2984 KiB  
Review
Application of Starch, Cellulose, and Their Derivatives in the Development of Microparticle Drug-Delivery Systems
by Paolina Lukova, Plamen Katsarov and Bissera Pilicheva
Polymers 2023, 15(17), 3615; https://doi.org/10.3390/polym15173615 - 31 Aug 2023
Cited by 20 | Viewed by 5350
Abstract
Micro- and nanotechnologies have been intensively studied in recent years as novel platforms for targeting and controlling the delivery of various pharmaceutical substances. Microparticulate drug delivery systems for oral, parenteral, or topical administration are multiple unit formulations, considered as powerful therapeutic tools for [...] Read more.
Micro- and nanotechnologies have been intensively studied in recent years as novel platforms for targeting and controlling the delivery of various pharmaceutical substances. Microparticulate drug delivery systems for oral, parenteral, or topical administration are multiple unit formulations, considered as powerful therapeutic tools for the treatment of various diseases, providing sustained drug release, enhanced drug stability, and precise dosing and directing the active substance to specific sites in the organism. The properties of these pharmaceutical formulations are highly dependent on the characteristics of the polymers used as drug carriers for their preparation. Starch and cellulose are among the most preferred biomaterials for biomedical applications due to their biocompatibility, biodegradability, and lack of toxicity. These polysaccharides and their derivatives, like dextrins (maltodextrin, cyclodextrins), ethylcellulose, methylcellulose, hydroxypropyl methylcellulose, carboxy methylcellulose, etc., have been widely used in pharmaceutical technology as excipients for the preparation of solid, semi-solid, and liquid dosage forms. Due to their accessibility and relatively easy particle-forming properties, starch and cellulose are promising materials for designing drug-loaded microparticles for various therapeutic applications. This study aims to summarize some of the basic characteristics of starch and cellulose derivatives related to their potential utilization as microparticulate drug carriers in the pharmaceutical field. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

35 pages, 2091 KiB  
Review
Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy
by Xuebing Li, Junda Liu and Neng Qiu
Polymers 2023, 15(6), 1400; https://doi.org/10.3390/polym15061400 - 11 Mar 2023
Cited by 14 | Viewed by 2971
Abstract
Cyclodextrins (CDs) are one of the most extensively studied cyclic-oligosaccharides due to their low toxicity, good biodegradability and biocompatibility, facile chemical modification, and unique inclusion capacity. However, problems such as poor pharmacokinetics, plasma membrane disruption, hemolytic effects and a lack of target specificity [...] Read more.
Cyclodextrins (CDs) are one of the most extensively studied cyclic-oligosaccharides due to their low toxicity, good biodegradability and biocompatibility, facile chemical modification, and unique inclusion capacity. However, problems such as poor pharmacokinetics, plasma membrane disruption, hemolytic effects and a lack of target specificity still exist for their applications as drug carriers. Recently, polymers have been introduced into CDs to combine the advantages of both biomaterials for the superior delivery of anticancer agents in cancer treatment. In this review, we summarize four types of CD-based polymeric carriers for the delivery of chemotherapeutics or gene agents for cancer therapy. These CD-based polymers were classified based on their structural properties. Most of the CD-based polymers were amphiphilic with the introduction of hydrophobic/hydrophilic segments and were able to form nanoassemblies. Anticancer drugs could be included in the cavity of CDs, encapsulated in the nanoparticles or conjugated on the CD-based polymers. In addition, the unique structures of CDs enable the functionalization of targeting agents and stimuli-responsive materials to realize the targeting and precise release of anticancer agents. In summary, CD-based polymers are attractive carriers for anticancer agents. Full article
(This article belongs to the Special Issue Polymeric Materials for Drug Delivery II)
Show Figures

Figure 1

Back to TopTop